Categories AlphaGraphs, Earnings, Health Care
Earnings: Trxade Health (MEDS) reports 16% rise in FY22 revenue; loss narrows
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a double-digit increase in revenues for fiscal 2022. The company’s full-year net loss narrowed from the prior year.
Revenues increased 16% from last year to $11.45 million. As a result, the net loss attributable to Trxade Health narrowed to $3.47 million or $0.41 per share in fiscal 2022 from $5.32 million or $0.65 per share in the twelve months ended December 2021.
“I am pleased with the growth we have experienced in our Trxade platform. We continue to achieve key milestones in our internal roadmap with a focus on innovation and development through our various complementary growth opportunities,” said Trxade’s CEO Suren Ajjarapu.
Trxade’s stock has gained about 52% since the beginning of the year. The shares closed Monday’s regular trading session sharply higher.
Prior Performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Infographic: How Lennar Corporation (LEN) performed in Q3 2024
Lennar Corporation (NYSE: LEN) reported total revenues of $9.4 billion for the third quarter of 2024, which was up 8% from the same period last year. Net earnings attributable to
FDX Earnings: FedEx Q1 2025 revenue and profit miss analysts’ estimates
Cargo giant FedEx Corporation (NYSE: FDX) Thursday reported a decrease in revenues and adjusted earnings for the first quarter of 2025. The results also fell short of expectations. First-quarter earnings,
Signet (SIG) remains optimistic about its fiscal year 2025 performance, here’s why
Shares of Signet Jewelers Limited (NYSE: SIG) were up over 4% on Thursday. The stock has gained 24% over the past one month. The jewelry retailer saw revenue and profits
